Silverview Closes Loan to Diagnostic Platform

Silverview Credit Partners closed a $30.0 million senior secured credit facility to support the formation and acquisition strategy of a newly created diagnostics platform.

The Company recently completed the acquisition of an established clinical laboratory providing molecular, toxicology, and genetic testing services.

Initial proceeds from the Loan were used to fund the acquisition and pay transaction-related expenses. The remaining undrawn facility will support the Company’s inorganic growth strategy and general corporate purposes.

‍